Economy

Integra LifeSciences Holdings Corporation

Edwards Lifesciences Corp Com now has $23.60B valuation. The Firm focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. The stock has "Hold" rating by Cowen & Co on Tuesday, August 22. Therefore 77% are positive. Independent Portfolio Consultants Inc reported 12,075 shares. About shares traded. Integra Lifesciences Holdings Corp (NASDAQ:IART) has risen 32.67% since September 14, 2016 and is uptrending.

More notable recent Edwards Lifesciences Corp (NYSE:EW) news were published by: Finance.Yahoo.com which released: "Here's Why Investors Should Buy Edwards Lifesciences Now" on August 17, 2017, also Nasdaq.com with their article: "Why the Earnings Streak Will Continue for Edwards Lifesciences (EW)" published on September 12, 2017, Nasdaq.com published: "Scholtz & Company, Llc Buys Edwards Lifesciences Corp, Cotiviti Holdings Inc ..." on August 14, 2017. Advisor Group Inc. increased its position in Integra LifeSciences Holdings Corporation by 0.8% in the third quarter. Dorian LPG Ltd (NYSE:LPG) has declined 2.04% since September 13, 2016 and is downtrending. The rating was maintained by Leerink Swann with "Outperform" on Monday, April 4. Edwards Lifesciences Corp had 76 analyst reports since July 30, 2015 according to SRatingsIntel. The Westwood Holdings Group Inc holds 79,757 shares with $6.84M value, down from 530,185 last quarter. Raymond James maintained the stock with "Outperform" rating in Thursday, July 27 report. As per Tuesday, January 26, the company rating was downgraded by Wells Fargo. The stock of Edwards Lifesciences Corp (NYSE:EW) earned "Buy" rating by UBS on Tuesday, September 22. The stock's average target of $4.75 is 58.86% above today's ($2.99) share price. Finally, RBC Capital Markets restated a "sector perform" rating and issued a $46.00 target price (down from $85.00) on shares of Integra LifeSciences Holdings Corporation in a research note on Friday, January 13th.

07/13/2016 - Integra LifeSciences Holdings Corporation had its "overweight" rating reiterated by analysts at JP Morgan. The firm has "Buy" rating by Oppenheimer given on Wednesday, July 26.

Edwards Lifesciences Corporation is a maker of heart valve systems and fix products used to replace or fix a patient's diseased or defective heart valve. D E Shaw accumulated 27,760 shares. Five equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Barclays Public Limited owns 0% invested in Integra Lifesciences Holdings Corp (NASDAQ:IART) for 46,532 shares. Colony Gru Limited Liability Company accumulated 0.04% or 3,166 shares. The firm has a market cap of $4.09 billion, a P/E ratio of 63.90 and a beta of 0.73. On Friday, October 16 the stock rating was initiated by Cantor Fitzgerald with "Hold". The life sciences company reported $0.45 EPS for the quarter, hitting analysts' consensus estimates of $0.45. Credit Suisse Ag holds 0% or 33,735 shares in its portfolio. The company now has an average rating of "Buy" and an average price target of $120.75. Citadel Ltd Com holds 0% or 9,812 shares.

01/06/2017 - Integra LifeSciences Holdings Corporation was upgraded to "market outperform" by analysts at JMP Securities. Vaughan Nelson Investment Management Lp reported 312,375 shares stake. (NASDAQ:IART), 11 have Buy rating, 0 Sell and 2 Hold. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue fix and tissue regeneration products, and small bone fixation and joint replacement solutions.

Moreover, Bard Associates Inc has 1.58% invested in the company for 142,560 shares. Its down 5.62, from 6.76 in 2016Q3. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Integra LifeSciences Holdings Corporation by 223.6% in the first quarter. The stock of Celgene Corporation (NASDAQ:CELG) earned "Buy" rating by Mizuho on Thursday, June 1. Massachusetts Financial Services Communications Ma has invested 0.02% of its portfolio in Integra Lifesciences Holdings Corp (NASDAQ:IART). Oppenheimer maintained the shares of IART in report on Wednesday, July 26 with "Buy" rating. Loomis Sayles & L P stated it has 167,428 shares. Gsa Cap Ptnrs Ltd Liability Partnership, a United Kingdom-based fund reported 2,608 shares. The New York-based Amalgamated Retail Bank has invested 0.02% in Integra Lifesciences Holdings Corp (NASDAQ:IART). Millennium Management Llc holds 322,951 shares or 0.06% of its portfolio. The original version of this piece of content can be accessed at https://stocknewstimes.com/2017/09/14/legal-general-group-plc-grows-stake-in-integra-lifesciences-holdings-corporation-iart.html.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

loading...
loading...

Latest


14 September 2017
Mortgage rates hold at 2017 lows, Freddie Mac says
Freddie's chief economist says rates may move higher following sharp gains this week in the 10-year Treasury yield. We are building a better housing finance system for homebuyers, renters, lenders and taxpayers.

14 September 2017
Steelers' physicality will be a challenge for Vikings
When their only game is against the best running back in the National Football League you have to wonder how that happens. Pittsburgh will go on the road in their next two games at the Chicago Bears and at the Baltimore Ravens.

14 September 2017
Apple Inc. (AAPL) Watch Dominates A Dying Industry
Apple still compares itself to watch companies even though it is not positioning its watch for fitness, like wearable makers do. We can only wait until next year to find out if the Apple Watch is able to maintain its position as the No. 1 watch globally.

14 September 2017
DeShaun Watson Expected to Start For Texans
O'Brien is expected to receive criticisms if Watson really will be the starter against the Bengals. The Bengals lost 20-0, and quarterback Andy Dalton looked disgusting .

14 September 2017
Ontario premier, Opposition leader in standoff over comments made about Wynne
Her lawyers are discussing the next steps, Wynne said. "No one wants to see a sitting premier debased", he said. Sorbara pleaded not guilty when the trial began last Thursday before Judge Howard Borenstein.

14 September 2017
Atypical renewed for S2 at Netflix
Seth Gordon executive produces the Sony Pictures Television Studios-produced comedy via his studio-based production company. Jennifer Jason Leigh stars as Sam's mother, Elsa, who is on a life-changing path as her son gains more independence.

14 September 2017
CDOT Announces Colorado As Winner For Hyperloop Route Concept
The winning route would make several stops between Pueblo and Cheyenne, and even head out west to Vail. The Hyperloop One will carry passengers and cargo in a pod that travels via a low-pressure tube.

14 September 2017
Lawyer disappointed Shkreli's bail was revoked
He faces a maximum of 20 years in prison, though the term could end up being shorter under federal sentencing guidelines. Shkreli said the Facebook post , which prompted a Secret Service investigation, was a joke and he meant no harm.

14 September 2017
This Is Who Paul Plans on Taking to Final 2
Kevin and Alex are on the chopping block at the end of the episode, with Paul already having said he wouldn't use his veto. After throwing comps for the past two weeks, the returning vet decided it was time to give it his all.

14 September 2017
Most Americans Oppose DACA Repeal, Support Path to Citizenship for 'Dreamers'
Dreamers were not the ones to suddenly decide that they should cross over the border to try to survive in a different country. It is ultimately up to Congress to act to preserve the program before the DACA recipients begin losing their status.